Month: February 2021

PALO ALTO, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) —First quarter GAAP diluted net earnings per share (“EPS”) of $0.83, above the previously provided outlook of $0.58 to $0.64 per shareFirst quarter non-GAAP diluted net EPS of $0.92, above the previously provided outlook of $0.64 to $0.70 per shareFirst quarter net revenue of $15.6 billion, up 7.0% from the prior-year periodFirst quarter net cash provided by operating activities of $1.0 billion, free cash flow of $0.9 billionFirst quarter returned $1.6 billion to shareholders in the form of share repurchases and dividendsNotes to tableInformation about HP Inc.’s use of non-GAAP financial information is provided under “Use of non-GAAP financial information” below.Net revenue and EPS resultsHP Inc. and its subsidiaries (“HP”) announced fiscal 2021 first...

BUENOS AIRES, Argentina, Feb. 25, 2021 (GLOBE NEWSWIRE) — MercadoLibre, Inc. (Nasdaq:MELI) (http://www.mercadolibre.com) intends to release financial results for its third fiscal quarter ended December 31st, 2020 on March 1st, 2020.The Company will host a conference call and audio webcast on March 1st, at 4:30 p.m. Eastern Time.The conference call may be accessed by dialing (877) 303-7209 / (970) 315-0420 (Conference ID – 4762658 –) and requesting inclusion in the call for Mercado Libre. The live conference call can be accessed via audio webcast at the investor relations section of the Company’s website, at http://investor.mercadolibre.com. An archive of the webcast will be available for one week following the conclusion of the conference call.About MercadoLibreMercadoLibre hosts the largest online commerce and payments ecosystem...

  

— AMONDYS 45 is Sarepta’s third RNA exon-skipping treatment for DMD approved in the U.S. —— Commercial distribution of AMONDYS 45 in the U.S. will commence immediately —— Information for patients and clinicians is available at www.SareptAssist.com —CAMBRIDGE, Mass., Feb. 25, 2021 (GLOBE NEWSWIRE) —  Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved AMONDYS 45 (casimersen). AMONDYS 45 is an antisense oligonucleotide from Sarepta’s phosphorodiamidate morpholino oligomer (PMO) platform, indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients with a confirmed mutation amenable to exon 45 skipping. This indication is based on a statistically significant...

TORONTO, Feb. 25, 2021 (GLOBE NEWSWIRE) — Sprott Inc. (“Sprott” or the “Company”) (NYSE/TSX: SII) announced today that its Board of Directors has declared a fourth quarter 2020 dividend of US$0.25 per common share, payable on March 23, 2021 to shareholders of record at the close of business on March 8, 2021.Registered shareholders who are residents of Canada as reflected in the Company’s shareholders register, as well as beneficial holders (i.e., shareholders who hold their common shares through a broker or other intermediary) whose intermediary is a participant in CDS Clearing and Depositary Services Inc. or its nominee, CDS & Co. (“CDS”), will receive their dividend in Canadian dollars, calculated based on the spot price exchange rate on March 23, 2021. Registered shareholders resident outside of Canada as reflected in Sprott’s...

GLEN HEAD, N.Y., Feb. 25, 2021 (GLOBE NEWSWIRE) — The First of Long Island Corporation (Nasdaq: FLIC) announced today the declaration of a first quarter cash dividend in the amount of $.19 per share. This represents a 5.6% increase over the dividend of $.18 per share declared in the same quarter last year. The dividend will be paid on March 19, 2021 to shareholders of record on March 10, 2021.The First National Bank of Long Island is the sole subsidiary of The First of Long Island Corporation. The Bank currently has forty-seven branches in Nassau and Suffolk Counties, Long Island and the boroughs of Queens, Brooklyn and Manhattan.For More Information Contact:Jay McConie, EVP & CFO(516) 671-4900, Ext. 7404 

Ársreikningur Félagsbústaða 2020Stjórn Félagsbústaða hf. samþykkti ársreikning félagsins 2020 á fundi sínum í dag 25. febrúar.Hagnaður vegna hækkunar á eignasafni Hagnaður félagsins nam 1.443 m.kr. er hann allur tilkominn vegna hækkunar á virði eigna, sá hagnaður verður ekki innleystur nema með eignasölu.Sjóðstreymi Félagsbústaða sýnir að handbært fé frá rekstri var 727 m.kr. samanborið við 1.059 m.kr. árið áður. Afborganir langtíma lána námu 952 m.kr. Helstu kennitölur reikningsins eru:Rekstrartekjur ársins námu 4.661 m.kr.Afkoma ársins fyrir fjármagnsliði (EBIT) nam 2.149 m.kr. eða 46,1% af rekstrartekjumMatshækkun fjárfestingareigna á árinu námu 1.742 m.kr.Söluhagnaður vegna sölu á Hallveigarstíg 1 nam 157 m.kr.Virði fjárfestingareigna í lok ársins er 99.103 m.kr.Eigið fé í lok ársins er 48.820 m.kr.Eiginfjárhlutfall í lok ársins er...

ATOS SEA European public limited-liability company (“Societas Europea”)with a share capital of 109,993,166 eurosRegistered office: River Ouest, 80 Quai Voltaire – 95870 BEZONSPontoise Registry of Commerce and Companies: 323 623 603Disclosure of trading in own sharesParis, February 25, 2021: Pursuant to applicable law on share buyback, Atos SE declares the following transactions in its own shares totaling € 23.9 million from Friday, February 19, 2021 to Wednesday, February 24, 2021, as part of the mandate given to a financial intermediary as announced by the Group on Friday, February 19, 2021.The detailed list of transactions is available on atos.net in the section Regulated Information [link].ContactsInvestor Relations:              Gilles Arditti                 +33 1 73 26 00 66                                                                      ...

ATOS SESociété Européenne au capital de 109 993 166 eurosSiège social : River Ouest – 80 Quai Voltaire – 95870 BEZONS323 623 603 RCS PONTOISEDéclaration des transactions sur actions propresParis, 25 février 2021 : Conformément à la réglementation relative aux rachats d’actions, Atos SE déclare ci-après les opérations d’achats d’actions propres pour un montant de 23,9 millions d’euros réalisées du vendredi 19 février 2021 au mercredi 24 février 2021 dans le cadre d’un mandat confié à un prestataire de services d’investissements, tel qu’annoncé par le Groupe, le vendredi 19 février 2021.La liste des transactions sous une forme détaillée est disponible sur notre site atos.net dans la rubrique information réglementée [lien].ContactsRelations Investisseurs :                 Gilles Arditti                 +33 1 73 26 00 66                                              ...